Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Colombo

Showing results (381-390 of 633) with videos related to

Pageof 64
Sort By:
The International Journal of Artificial Organs|September 10, 2020
Predicting post-LVAD outcome: Is there a role for cognition?Marykay A Pavol, Amelia K Boehme, Joshua Z Willey, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 28, 2023
Comparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failureMichael Kirschner, Veli K Topkara, Jocelyn Sun, et al.
The Annals of Thoracic Surgery|March 10, 2019
Midterm Outcomes of Bridge-to-Recovery Patients After Short-Term Mechanical Circulatory SupportYi-Tso Cheng, Arthur R Garan, Joseph Sanchez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 24, 2020
PREVENTion of non-surgical bleeding by management of HeartMate II patients without anti-platelet therapy (PREVENT II) trialUlrich P Jorde, Jason N Katz, Paolo C Colombo, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 19, 2016
Bridge to durable left ventricular assist device for refractory cardiogenic shockDaisuke Yoshioka, Hiroo Takayama, Arthur R Garan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 6, 2016
Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantationKevin J Clerkin, Maryjane A Farr, Susan W Restaino, et al.
International Immunology|July 1, 2004
Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivityJohn S Manavalan, Seunghee Kim-Schulze, Luigi Scotto, et al.
Interactive Cardiovascular and Thoracic Surgery|November 7, 2017
Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devicesDaisuke Yoshioka, Boyangzi Li, Hiroo Takayama, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 27, 2007
Liver disease as risk factor for cystic fibrosis-related diabetes developmentL Minicucci, R Lorini, A Giannattasio, et al.
Journal of Palliative Medicine|June 7, 2018
End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination TherapyShunichi Nakagawa, Arthur R Garan, Hiroo Takayama, et al.
Pageof 64

Showing results (381-390 of 633) with videos related to

Sort By:
Pageof 64
The International Journal of Artificial Organs|September 10, 2020
Predicting post-LVAD outcome: Is there a role for cognition?Marykay A Pavol, Amelia K Boehme, Joshua Z Willey, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 28, 2023
Comparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failureMichael Kirschner, Veli K Topkara, Jocelyn Sun, et al.
The Annals of Thoracic Surgery|March 10, 2019
Midterm Outcomes of Bridge-to-Recovery Patients After Short-Term Mechanical Circulatory SupportYi-Tso Cheng, Arthur R Garan, Joseph Sanchez, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 24, 2020
PREVENTion of non-surgical bleeding by management of HeartMate II patients without anti-platelet therapy (PREVENT II) trialUlrich P Jorde, Jason N Katz, Paolo C Colombo, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 19, 2016
Bridge to durable left ventricular assist device for refractory cardiogenic shockDaisuke Yoshioka, Hiroo Takayama, Arthur R Garan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 6, 2016
Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantationKevin J Clerkin, Maryjane A Farr, Susan W Restaino, et al.
International Immunology|July 1, 2004
Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivityJohn S Manavalan, Seunghee Kim-Schulze, Luigi Scotto, et al.
Interactive Cardiovascular and Thoracic Surgery|November 7, 2017
Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devicesDaisuke Yoshioka, Boyangzi Li, Hiroo Takayama, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 27, 2007
Liver disease as risk factor for cystic fibrosis-related diabetes developmentL Minicucci, R Lorini, A Giannattasio, et al.
Journal of Palliative Medicine|June 7, 2018
End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination TherapyShunichi Nakagawa, Arthur R Garan, Hiroo Takayama, et al.
Pageof 64